Our research also highlights a unique TME in cardiac sarcoma, marked by an increase in myeloid‐derived suppressor cells, specifically SPP1+ and OLR1+ macrophages, which are implicated in advanced tumour progression. This evidence concerns the gene OLR1 and neoplasm.